Opening book details…
Can I read Protein Kinase Inhibitors : From Discovery to Therapeutics on EtoBox?
Protein Kinase Inhibitors : From Discovery to Therapeutics by Md. Imtaiyaz Hassan; Saba Noor is a nonfiction available to read on EtoBox.
What is Protein Kinase Inhibitors : From Discovery to Therapeutics about?
Protein Kinase Inhibitors: From Discovery to Therapeutics offers a foundational, pragmatic overview of protein kinases inhibitors and their potential role in disease modulation and treatment. Here, international experts in the field offer an integrated discussion of kinase inhibitor biology, biomarker discovery, and methods for drug design and development. After a brief overview of kinases and kinase inhibitors, subsequent chapters discuss individual kinases that are representative of the wider kinases and kinase families, including their roles in disease pathogenesis, underlying mechanisms, potential inhibitors and their modes of action for therapeutic modulation. Several potential drugs under different stages of clinical trials are discussed, including their relevance to cancer, diabetes, obesity, cardiovascular, neurological, and auto-immune and inflammatory disease, among other disorders. The book also addresses the challenges and opportunities for future kinase inhibitor development. Provides a thorough overview of kinase inhibitor biology and its role in disease progression and modulation Examines protein kinase inhibitor drugs in various stages of clinical trials and develop
Who reads Protein Kinase Inhibitors : From Discovery to Therapeutics?
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Md. Imtaiyaz Hassan; Saba Noor
- Publisher
- ELSEVIER ACADEMIC PRESS
- Published
- 2022
- Language
- EN
- ISBN
- 9780323912877
- Category
- nonfiction
- Subjects
- Science, Chemistry, Biology
More by Md. Imtaiyaz Hassan; Saba Noor
Browse all works by Md. Imtaiyaz Hassan; Saba Noor
Similar books
- Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development) — Mark Pearson PhD, Carlos García-Echeverría PhD (auth.), Doriano Fabbro PhD, Frank McCormick MD, (2006)
- Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics) — Daniele Focosi (2016)
- Protein Kinase Technologies (Neuromethods (68)) — Kazuhiro Aoki, Naoki Komatsu, Akihiro Goto, Michiyuki Matsuda (auth.), Hideyuki Mukai (2012)
- Cyclin-dependent Kinase (cdk) Inhibitors: Methods And Protocols (methods In Molecular Biology) — Mar Orzáez, Mónica Sancho Medina, Enrique Pérez-Payá (2016)
- AMP-activated Protein Kinase (Experientia Supplementum, 107) — Mario D. Cordero, Benoit Viollet (2016)
- Protein Kinase C In Cancer Signaling And Therapy (current Cancer Research) — Alex Toker (auth.), Marcelo G. Kazanietz (2010)